Industry trends

Jay Keasling's team fully biosynthesizes QS-21 in engineered yeast making it more economical to produce potent adjuvants and reduce vaccine costs

Date:May 09,2024
Author:Angelo Corporation - Reprinted by: SynBio


Recommend Company News